The patent expiry on March 20 clears the way for Indian drugmakers to legally manufacture and market generic versions, triggering a scramble among leading pharmaceutical companies including Sun Pharma, Dr Reddys, Torrent Cipla, Zydus Lifesciences and Lupin
Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes
If Novo Nordisk's Q3 2026 timeline holds, the earliest semaglutide could be removed from the shortage list is October 2026, with compounding pharmacies required to stop production by December 2026
The GIP receptor activation may specifically influence how the body handles fat storage and mobilization, providing a metabolic advantage beyond simple caloric restriction
Are there any risks or side effects associated with glutathione supplementation for liver health
Semaglutide works with diet and exercise